Tweet from EricTopol at October 14, 2021 at 09:27AM
The benefit of the Pfizer boosters across all age groups (vs infections in 16+, vs severe disease 40+), presented @US_FDA today as background for consideration of other vaccine boosters
https://t.co/D410x8zuDo https://t.co/4xBqO6oMec— Eric Topol (@EricTopol)
Oct 14, 2021
from http://twitter.com/EricTopol